Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis
Open Access
- 5 January 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 39 (1), 204-210
- https://doi.org/10.1002/hep.20029
Abstract
Patients with primary sclerosing cholangitis (PSC) may develop and bleed from esophageal varices. However, the exact prevalence of esophageal varices in patients with PSC remains unknown and potential predictors of esophageal varices in this population have not been identified. Our aim was to determine the prevalence of esophageal varices in patients with PSC and the variables that predict their presence. Data were collected on 283 patients with PSC treated for the first time at the Mayo Clinic (Rochester, MN) during 8 consecutive years. Thirty-six percent (102 of 283) of patients had esophageal varices including 56% (57 of 102) with moderate/large varices. After excluding 28 patients with a history of variceal bleeding, data on 183 patients were analyzed to identify independent predictors of esophageal varices and of moderate/large size varices. Platelet count, albumin level, and advanced histologic disease were independent predictors of esophageal varices (area under the receiver operator characteristic [ROC] curve = 0.88). After controlling for the presence of advanced histologic stage and albumin levels, the odds ratios (OR) of platelet count less than 150 × 103/dL for the presence of esophageal varices was 6.3 (95% CI: 2.6–15.8). The diagnostic accuracy of these results was corroborated by cross-validation of the data in an independent set of 72 patients with PSC (area under the ROC = 0.90). In conclusion, in patients with PSC, noninvasive markers of portal hypertension and of advanced liver disease predict the presence of esophageal varices. Our results suggest a clinically applicable and useful approach to identify patients with PSC who are more likely to benefit from endoscopic screening for esophageal varices. (HEPATOLOGY 2004;39:204–210.)This publication has 20 references indexed in Scilit:
- Is There A Role for Liver Biopsy in Primary Sclerosing Cholangitis?The American Journal of Gastroenterology, 2003
- A Revised Natural History Model for Primary Sclerosing CholangitisMayo Clinic Proceedings, 2000
- Time Course of Histological Progression in Primary Sclerosing CholangitisThe American Journal of Gastroenterology, 1999
- Primary sclerosing cholangitisHepatology, 1999
- Portal hypertension and variceal bleeding: An AASLD single topic symposiumHepatology, 1998
- Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varicesHepatology, 1997
- Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosisHepatology, 1996
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesThe New England Journal of Medicine, 1991
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesThe New England Journal of Medicine, 1988
- Primary sclerosing cholangitis: findings on cholangiography and pancreatography.Radiology, 1983